Welcome to our dedicated page for reAlpha Tech SEC filings (Ticker: AIRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
reAlpha Tech Corp.'s SEC filings document an AI-powered real estate technology company with Nasdaq-listed common stock and an emerging growth company reporting status. Recent 8-K filings cover financial results, business highlights, non-GAAP reconciliations, investor presentation materials and operating updates tied to the company’s homebuying platform, mortgage brokerage, realty services and AiChat technology operations.
The filings also record capital-structure and governance matters, including a 1-for-25 reverse stock split, charter amendments, Nasdaq listing-rule notifications, audit committee composition, executive separation arrangements and restructuring actions. These disclosures describe material events affecting reAlpha’s reporting obligations, board oversight, equity structure and operating cost profile.
reAlpha Tech Corp. reported that it is temporarily out of compliance with a Nasdaq listing rule after a board change. Director Brian Cole resigned, creating a vacancy on the company’s three‑member audit committee, which now has only two members, contrary to Nasdaq Listing Rule 5605(c)(2)(A).
The company notified Nasdaq of this non-compliance and plans to use the cure period allowed under Nasdaq Rule 5605(c)(4)(B). reAlpha intends to appoint a new independent director to the board and audit committee by the earlier of its next annual stockholder meeting or 180 days after Cole’s resignation becomes effective. In addition, director Monaz Karkaria also resigned from the board and its committees. The company stated that both resignations were not due to any disagreement regarding its operations, policies, or practices.
reAlpha Tech Corp. Chief Financial Officer Piyush Phadke received two stock-based awards totaling 477,612 restricted stock units (RSUs) on January 30, 2026. One grant covers 295,637 RSUs tied to performance under the 2025 Short-Term Incentive Plan, and another 181,975 RSUs compensates executive service for the quarter ended December 31, 2025.
Each RSU converts into one share of common stock at no purchase price. For both awards, 50% vests 12 months after grant, with the remaining 50% vesting in four equal quarterly installments over the following year, contingent on continued service and plan compliance; unvested RSUs are forfeited upon separation. After these grants, Phadke directly holds 1,057,939 shares of common stock.
reAlpha Tech Corp.'s Chief Executive Officer Michael J. Logozzo reported stock-based awards tied to performance and service. On January 30, 2026, he received 239,136 restricted stock units (RSUs) for achieving performance goals for the quarter ended December 31, 2025, and 198,518 RSUs as compensation for executive services for the quarter ended December 31, 2026.
Each RSU converts into one share of common stock at no purchase price. For both grants, 50% vest 12 months after the grant date and the remaining 50% vest in four equal quarterly installments over the following 12 months, if he remains in service and meets plan conditions; unvested RSUs are forfeited upon separation. Following these grants, he directly beneficially owned 1,011,060 common shares and had an additional 2,199,938 shares reported as indirectly owned through his spouse.
reAlpha Tech Corp director Monaz Karkaria reported receiving 14,778 shares of common stock on January 30, 2026. The shares were granted at $0 per share as quarterly compensation for services as a non-executive director under the company’s 2022 Equity Incentive Plan.
The number of shares was based on the 10-day volume weighted average of the Nasdaq Official Closing Price of reAlpha’s common stock ending on and including January 30, 2026. Following this grant, Karkaria beneficially owns 2,962,769 common shares, held directly.
reAlpha Tech Corp.'s Executive Chairman and director Giri Devanur reported multiple stock awards dated January 30, 2026. He received 14,778 shares of common stock as quarterly compensation for non-executive director services under the 2022 Equity Incentive Plan.
He was also granted 234,021 restricted stock units under the 2025 Short-Term Incentive Plan for performance in the quarter ended December 31, 2025, and 165,431 restricted stock units as executive officer compensation for the same period. Each RSU converts into one share, with 50% vesting 12 months after grant and the rest vesting in four equal quarterly installments over the following 12 months, subject to continued service and plan terms.
Following these awards, Devanur directly beneficially owns 25,944,710 shares of common stock and indirectly holds 2,700,000 additional shares through Giri Devanur Holdings LLC, where he has sole voting and investment power.
reAlpha Tech Corp. director receives stock as quarterly pay
Director Dimitrios Angelis acquired 14,778 shares of reAlpha Tech Corp. common stock on January 30, 2026 as quarterly compensation for his services as a non-executive director under the company’s 2022 Equity Incentive Plan. The shares were issued at a price of $0.
After this equity grant, Angelis directly beneficially owned 64,283 shares of reAlpha Tech Corp. common stock. The number of shares granted was calculated using the 10-day volume weighted average of the Nasdaq Official Closing Price of the company’s stock ending on and including January 30, 2026.
reAlpha Tech Corp. director receives stock compensation. On January 30, 2026, non-executive director Balaji Swaminathan was awarded 14,778 shares of common stock of reAlpha Tech Corp. as quarterly compensation under the company’s 2022 Equity Incentive Plan at a price of $0 per share.
Following this grant, Swaminathan directly beneficially owns 64,283 shares of reAlpha Tech Corp. common stock. The share amount for this award was calculated using the 10-day volume-weighted average of the Nasdaq Official Closing Price of the company’s common stock ending on and including January 30, 2026.
reAlpha Tech Corp. director Brian D. Cole received 14,778 shares of common stock as equity compensation. The shares were granted on January 30, 2026 at a stated price of $0 per share under the company’s 2022 Equity Incentive Plan.
After this stock grant, Cole directly beneficially owns 383,277 reAlpha Tech Corp. common shares. The number of shares awarded was based on the 10-day volume weighted average of the Nasdaq Official Closing Price of the company’s common stock ending on and including January 30, 2026, reflecting the company’s practice of using market-based pricing to determine board compensation in stock.
reAlpha Tech Corp. (AIRE) reported that it completed the acquisition of Prevu, Inc. through a merger on November 21, 2025, making Prevu a wholly owned subsidiary. The purchase price totals $4,500,000, including $750,000 in cash at closing and $1,250,000 in common stock, or 2,501,000 shares at $0.4998 per share issued at closing.
The remaining $2,500,000 is payable in four equal $625,000 installments over 18 months after closing, in cash or stock at reAlpha’s discretion, with stock valued using a 10‑day VWAP. All merger-related stock is subject to a 180‑day lockup, and total shares issued under the merger cannot exceed 25,599,604 shares (19.99% of shares outstanding before signing) without stockholder approval.
In a related transition agreement, a Prevu co‑founder received $100,000 in reAlpha stock, or 200,080 shares at $0.4998 per share. All shares are being issued in private transactions under Section 4(a)(2) and Rule 506 of Regulation D. reAlpha also furnished a press release and an investor presentation discussing the merger and business strategy.
reAlpha Tech Corp. (AIRE) has received a 180-day extension from Nasdaq to regain compliance with its $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company now has until May 18, 2026 for its common stock to close at or above $1.00 per share for at least 10 consecutive business days to cure the deficiency. The extension was granted because reAlpha meets other Nasdaq listing standards and has stated it may implement a reverse stock split if needed. If the company does not regain compliance by the end of the extension, Nasdaq may move to delist the stock, though reAlpha would have the right to appeal. The stock continues to trade on Nasdaq under the symbol AIRE.